Read the Tirzepatide Research Guide. Review the research context and evidence limitations.
TIRZ-GLP3 (30 mg) is supplied for controlled laboratory evaluation of Tirzepatide within Weight Loss / Metabolic Research studies.
- Research material: Tirzepatide
- Listed strength and format: 30 mg Vial
- Research category: Weight Loss / Metabolic Research
Tirzepatide 30 mg receptor-research context
TIRZ-GLP3 is the SRP listing name used here for Tirzepatide. The LY3298176 discovery study characterizes its dual GIP and GLP-1 receptor activity. This differs from Semaglutide and from RTZ-GLP3 / retatrutide; compare compound identity as well as vial amount.
This page is for 30 mg total material. The nearby size links show the separate Tirzepatide listings and their current prices. Contact SRP for product and batch questions. Research publications do not verify the supplied lot or establish suitability for personal use.
For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.













Reviews
There are no reviews yet.